Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$894K Sell
20,906
-73,150
-78% -$2.92M 0.84% 38
2017
Q3
$3.45M Buy
+94,056
New +$3.8M 0.82% 50
2014
Q2
Sell
-99,430
Closed -$2.14M 198
2014
Q1
$2.14M Sell
99,430
-46,201
-32% -$997K 0.34% 73
2013
Q4
$3.25M Sell
145,631
-11,793
-7% -$260K 0.49% 68
2013
Q3
$3.25M Buy
+157,424
New +$3.35M 0.53% 67

Other funds holding HOLX

Croft-Leominster's HOLX Position: Q4 2017 in Review

Croft-Leominster reduced its Hologic (HOLX) stake by 78% in Q4 2017, selling an estimated $2.92M and leaving 20,906 shares worth $894K. The position accounts for 0.84% of the portfolio, ranked #38.

Croft-Leominster first reported a position in HOLX in Q3 2013 and has held it in 5 quarters since. The position peaked at $3.45M in Q3 2017. 472 funds tracked by Wall St. Rank hold HOLX as of Q4 2017.

  • Croft-Leominster held 20,906 shares of Hologic worth $894K as of Q4 2017.
  • Croft-Leominster sold 73,150 Hologic shares in Q4 2017, an estimated $2.92M.
  • Hologic made up 0.84% of Croft-Leominster's portfolio in Q4 2017, its #38 holding.
  • Croft-Leominster first reported a position in Hologic in Q3 2013 and has held it in 5 quarters since.
  • Croft-Leominster's Hologic position peaked at $3.45M in Q3 2017.
  • 472 funds tracked by Wall St. Rank held Hologic as of Q4 2017.

Based on Croft-Leominster's 13F filing for Q4 2017, filed 6 Mar 2018.